Can an online course help you live better with chronic disease?

NCT ID NCT06484322

Recruiting now Symptom relief Sponsor: Luleå Tekniska Universitet Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests a new internet-based program called SEE 2.0, designed to help people with chronic diseases like long-term pain, fatigue, or lung conditions manage their daily activities better. Researchers will enroll 40 adults aged 18-75 who struggle with everyday tasks. The program includes educational videos and self-reflection exercises to improve satisfaction, balance, and value in daily life. This is a small feasibility study to see if the approach works and can be used more widely.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: internet-based occupational therapy program (Strategies Empowering Activities in Everyday Life 2.0)
What this could lead to: If it works, this could offer a practical, home-based way for people with chronic conditions to feel more satisfied and balanced in their daily lives.
What could go wrong: This is a small feasibility study with only 40 participants, so results may not apply widely. The program requires self-motivation and internet access, which may limit its usefulness for some.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Chronic Disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC DISEASE

Contacts and locations

Locations

Luleå University of Technology
NOT_YET_RECRUITING

Luleå, 97187, Sweden
Luleå university of technology
RECRUITING

Luleå, None Selected, 971 87, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.